Role of the renin-angiotensin-aldosterone system in the progression of renal disease: A critical review

Seminars in Nephrology

Volumn 17, Issue 5, 1997, Pages 431-440

  Ibrahim, Hassan N ^a,b   Rosenberg, Mark E ^a   Hostetter, Thomas H ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST;

ADRENAL HYPERPLASIA; DISEASE COURSE; DISEASE SEVERITY; GLOMERULOSCLEROSIS; HEMODYNAMICS; HUMAN; HYPERTENSION; KIDNEY DISEASE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; DISEASE PROGRESSION; HEMODYNAMIC PROCESSES; KIDNEY DISEASES; RATS; RENIN-ANGIOTENSIN SYSTEM;

EID: 0030931894     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (84)

1. Anderson S, Rennke H, Brenner B: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77:1993-2000, 1986
2. Lafayette RA, Mayer G, Park SK, Meyer TW: Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 90:766-771, 1992
3. Rosenberg ME, Smith LJ, Correa-Rotter R, Hosteller TH: The paradox of the renin-angiotensin system in chronic renal disease. Kidney Int 45:403-410, 1994
4. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
5. Hostetter TH, Olson JL, Rennke HG, et al: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 241:F85-93, 1981
6. Neuringer JR, Anderson S, Brenner BM: The role of systemic and intraglomerular hypertension, in Mitch WE (ed): The Progressive Nature of Renal Disease. New York, NY, Churchill-Livingstone, 1992, pp 1-21
7. Meyer T, Rennke HG: Progressive glomerular injury after limited renal infarction in the rat. Am J Physiol 254:F856-F862, 1988
8. Skidgel RA, Schulz WW, Tam LT, Erdos EG: Human renal angiotensin I converting enzyme and neutral endopeptidase. Kidney Int 20:45-48, 1987 (suppl)
9. Zatz R, Dunn BR, Meyer TW, Anderson S, et al: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925-1930, 1986
10. Zoja C, Donadelli R, Corna D, et al: The renoprotective properties of angiotensin converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: Evidence based on comparative studies with a receptor antagonist. Am J Kidney Dis 29:254-264, 1997
11. Rosenberg ME, Correa-Rotter R, Inagami T, et al: Glomerular renin synthesis and storage in the remnant kidney. Kidney Int 40:677-683, 1991
12. Ylitalo P, Hepp R, Oster P, et al: Effects of varying sodium intake on blood pressure and renin-angiotensin system in subtotally nephrectomized rats. J Lab Clin Med 88:807-816, 1976
13. Ylitalo P, Gross F: Hemodynamic changes during the development of sodium induced hypertension in subtotally nephrectomized rats. Acta Physiol Scand 106:447-455, 1979
14. Dzau VJ, Burt DW, Pratt RE: Molecular biology of the renin-angiotensin system. Am J Physiol 255:F563-F573, 1988
15. Reams G, Villarreal D, Bauer JH. Intrarenal metabolism of angiotensin II. Am J Physiol 258:F1510-F1515, 1990
16. Mendelsohn FAO: Evidence for the local occurence of angiotensin II in rat kidney and its modulation by dietary sodium intake and converting enzyme blockade. Clin Sci Lond 57:173-179, 1979
17. Seikaly MG, Arant BS, Seney FD: Endogenous angiotensin concentrations in specific intrarenal compartments of the rat. J Clin Invest 86:1352-1357, 1990
18. Navar LG, Von Thun AM, Zon L, et al: Enhancement of intrarenal angiotensin II levels in 2 kidney 1 clip and angiotensin II induced hypertension. Blood Pressure 2:88-92, 1995
19. Unger T, Ganten D, Lang RE: Effect of converting enzyme inhibitors on tissue converting enzyme and angioten-sin II: Therapeutic implications. Am J Cardiol 59:18D-22D, 1987
20. Erdos EG, Skidgel RA: Renal metabolism of angiotensin I and II. Kidney Int 38:524, 1990
21. Anderson S, Ingelfinger JR, Hirsch AT, et al: Reninangiotensin system during evolution of nephrotic syndrome. Clin Res 38.-358A-S27, 1990 (abstr)
22. Patel R, Ansari A: Serum angiotensin converting enzyme activity in patients with chronic renal failure on long term hemodialysis. Clin Chim Acta 92:491-495, 1979
23. Liebermann J, Sastre A: Serum angiotensin-converting enzyme: Elevations in diabetes mellitus. Ann Intern Med 93:825-826, 1980
24. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, et al: An insertion deletion polymorphism in angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990
25. Yoshida H, Mitarai T, Kawamura T, et al: Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of the IgA nephropathy. J Clin Invest 96:2162-2169, 1995
26. Van Essen GG, Rensma EL, DeZeeuw D, et al: Association between angiotensin-converting enzyme gene polymorphism and failure of renoprotective therapy. Lancet 347:94-95, 1996
27. Parving HH, Jacobsen P, Tarnow L, et al: Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: Observational follow up study. Br Med J 313:591-594, 1996
28. Wolf G, Thaiss F, Scherberich SE: Glomerular angiotensinase A in the rat: Increase of enzyme activity following renal ablation. Kidney Int 38:862-868, 1990
29. Correa-Rotter R, Hostetter TH, Manivel JC, Rosenberg ME: Renin expression in renal ablation. Hypertension 20:483-490, 1992
30. Pupilli C, Chevalier RL, Carey RM, Gomez A: Distribution and content of renin and renin mRNA in remnant kidney of adult rat. Am J Physiol 263:F731-F738, 1992
31. Blantz RL, Konner KS, Tucker BJ: Angiotensin II effect upon the glomerular microcirculation and ultrafiltration coefficient of the rat. J Clin Invest 57:419-434, 1976
32. Loomis D, Jett-Jackson CE: Plastic studies in abnormal renal architecture. VI. An investigation of the circulation of infarcts in the kidney. Arch Pathol 33:735-769, 1942
33. Camillieri JP, Phat VN, Bariety J, et al: Use of a specific antiserum for renin detection in human kidney. J Histochem Cytochem 28:1343-1346, 1980
34. Yoshida Y, Fogo A, Shiraga H, et al: Serial-micropuncture analysis of single nephron function in subtotal renal ablation. Kidney Int 33:855-867, 1988
35. Lindop GBM, Lever AF: Anatomy of the renin angiotensin system in normal and pathological kidney. Histopathology 10:335-362, 1986
36. Torres VE, Donovan KA, Scicli G, et al: Synthesis of renin by tubulocystic epthelium in autosomal dominent polycystic kidney disease. Kidney Int 42:364-373, 1992
37. Daniels BS, Hostetter TH: Adverse effects of growth in the glomerular circulation. Am J Physiol 258:F1409-1416, 1990
38. Campbell-Boswell M, Robertson Jr. AL: Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Exp Mol Pathol 35:265-276, 1981
39. Simonian MH, Gill GN: Regulation of deoxyribonucleic acid synthesis in bovine adrenocortical cells in culture. Endocrinology 104:588-595, 1979
40. 1] angiotensin II receptor-mediated stimulation of protein synthesis in chick heart cells. Am J Physiol 258:H806-H813 1990
41. Wolf G, Neilson EG: Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells. Am J Physiol 259:F768-F777, 1990
42. Norman J, Badie-Dezfooly B, Nord EP, et al: EGF-induced mitogenesis in proximal tubular cells: poetentiation by angiotensin II. Am J Physiol 253:F299-F309, 1987
43. Ray PE, Aguilera G, Kopp JB, et al: Angiotensin II receptor-mediated proliferation of cultured human fetal mesangial cells. Kidney Int 40:764-771, 1991
44. Homma T, Hoover RL, Ichikawa I, Harris RC: Angiotensin II induces hypertrophy and stimulates collagen production in cultured rat glomerular mesangial cell. Clin Res 38:358A, 1990 (abstr)
45. Singhal PC, Franki N, Hays RM: Angiotensin II and norepinephrinee induces actin synthesis in cultured mesangial cells. Clin Res 38:401A, 1990 (abstr)
46. Rosenberg ME, Hosteller TH: The effect of angiotensin II and norepinephrine on early growth response genes in Ihe ral kidney. Kidney Int 43:601-609, 1993
47. Edigo J: Vasoactive hormones and renal sclerosis. Kidney Int 49:578-597, 1996
48. Chobanian MC, Julin CM: Angiotensin II stimulates ammoniagenesis in canine renal proximal tubule segmenls. Am J Physiol 260:F19-F26, 1991
49. 4Cl. J Clin Invest 84:1767-1779, 1989
50. Nath KA, Hosteller MK, Hosleller TH: Palhophysiology of chronic tubulo-interstitial disease in rats: Interaction of dietary acid load, ammonia, and complement component C3. J Clin Invest 76:667-675, 1985
51. Keane WF, Raij L: Relationship among altered glomerular barrier permselectivity, angiotensin II, and mesangial uptake of macromolecules. Lab Invest 52:599-604, 1985
52. Hall JE: Regulalion of glomerular fillralion rale and sodium excrelion by angiolensin II. Fed Proc 45:1431-1437, 1986
53. Nath KA, Croatt AJ, Hosteller TH: Oxygen consumption and oxidant stress in surviving nephrons. Am J Physiol 258:F1354-F1362, 1990
54. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW: Angiolensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141-1148, 1994
55. Greene E, Kren S, Hostetter TH: Role of aldosterone in the remnant kidney model in the rat. J Clin Invest 98:1063-1068, 1996
56. Morrison AB: Experimentally induced chronic renal insufficiency in the rat. Lab Invest 11:321-331, 1962
57. Quan ZY, Walser M, Hill GS: Adrenalectomy amelio-rates ablative nephropathy in the rat independently of corticosterone maintenance level. Kidney Int 41:326-333, 1992
58. Hene RJ, Boer P, Koomans HA, Mees EJD: Plasma aldosterone concentrations in chronic renal disease. Kidney Int 21:98-101, 1982
59. Berl T, Katz FH, Henrich WL, et al: Role of aldosterone in the control of sodium excretion in patients with advanced chronic renal failure. Kidney Int 14:228-235, 1978
60. Reams GP, Bauer JH: Effect of enalapril in subjects with hypertension associated with moderate to severe renal dysfunction. Arch Intern Med 146:2145-2148, 1986
61. Walker WG: Hypertension-related renal injury: A major contributor to end-stage renal disease. Am J Kidney Dis 22:164-173, 1993
62. Ruilope LM, Miranda B, Morales JM, et al: Converting enzyme inhibition in chronic renal failure. Am J Kidney Dis 13:120-126, 1989
63. Young DB, Smith Jr MJ, Jackson TE, Scott RE: Multiplicative interaction between angiotensin II and K concentration in stimulation of aldosterone. Am J Physiol 247:E328-E335, 1984
64. Pratt JH, Rothrock JK, Dominguez JH: Evidence that angiotensin-II and potassium collaborate to increase cytosolic calcium and stimulate the secretion of aldosterone. Endocrinology 125:2463-2489, 1989
65. Warren DJ, Ferris TF: Renin secretion in renal hypertension. Lancet 1:159-163, 1970
66. Griffin KA, Picken M, Bidani AK: Method of renal mass reduction is a critical modulator of subsequent injury and hypertension. J Am Soc Nephrol 4:2023-2031, 1994
67. Gretz N, Waldherr R, Strauch M: The remnant kidney model, in Gretz, Strauch M (eds): Experimental and Genetic Rat Models of Chronic Renal Failure. Basel, Karger, 1993, pp 1-28
68. Griffin KA, Picken M, Bidani AK: Differences in the potential functional and structural mediators of glomerulosclerosis between the infarction and surgical excision models of 5/6 renal mass reduction. J Am Soc Nephrol 7:1854-1855, 1996 (abstr)
69. Cowley AW: Long-term control of arterial blood pressure. Physiol Rev 72:231-278, 1992
70. Onoyama K, Bravo EL, Tarazi RC: Sodium, extracelleular fluid volume, and cardiac output changes in the genesis of mineralocorticoid hypertension in the intact dog. Hypertension 1:331-336, 1979
71. Pan Y, Young D: Experimental aldosterone hypertension in the dog. Hypertension 4:279-287, 1982
72. Purkerson ML, Hoffsten PE, Klahr S: Pathogenesis of the glomerulopathy associated with renal infarction in rats. Kidney Int 9:407-417, 1976
73. Lax DS, Benstein JA, Tolbert E, Dworkin LD: Effects of salt restriction on renal growth and glomerular injury in rats with remnant kidneys. Kidney Int 41:1527-1534, 1992
74. Brilla CG, Weber KT: Mineralocorticoid excess, dietary medium and myocardial fibrosis. J Lab Clin Med 120:893-901, 1992
75. Young M, Fullerton M, Dilley R, Funder J: Mineralocorticoids, hypertension and cardiac fibrosis. J Clin Invest 93:2578-2583, 1994
76. Todd-Turla KM, Schnermann J, Fejes-Toth G, et al: Distribution of mineralocorticoid and glucocorticoid receptor mRNA along the nephron. Am J Physiol 264:F781-F791, 1993
77. Wakisaka M, Spiro MJ, Spiro RG: Synthesis of type VI collagen by cultured glomerular cells and comparison of its regulation by glucose and other factors with that of type IV collagen. Diabetes 43:95-103, 1994
78. Kornel L: Colocalization of 11/3-hydroxysteroid dehydrogenase and mineralocorticoid receptors in cultured vascular smooth muscle cells. Am J Hypertens 7:100-103, 1994
79. Schlondorff D: The glomerular mesangial cell: An expanding role for a specialized pericyte. FASEB J 1:272-281, 1987
80. Floege J, Bums MW, Alpers CE, et al: Glomerular cell proliferation and PDGF expression precede glomerulo-sclerosis in the remnant kidney model. Kidney Int 41:297-309, 1992
81. Wehling M, Christ M, Theisen K: Membrane receptors for aldosterone: a novel pathway for mineralocorticoid action. Am J Physiol 263:E974-E979, 1992
82. Hakeyama H, Miramuri I, Fujita T, et al: Vascular aldosterone, biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem 269:24316-24370, 1994
83. Takeda Y, Miyamori I, Yoneda T, et al: Production of aldosterone in isolated rat blood vessels. Hypertension 25:170-173, 1995
84. Hosteller TH, Rosenberg ME, Kren S, Greene E: Aldosterone (ALDO) induces glomerular sclerosis in the remnant kidney. J Am Soc Nephrol 6:1016, 1996 (abstrt)